Home / Indicator library / Biotechnology and Medical Care / Lotus Pharm (1795) overview
Lotus Pharm (1795) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Lotus Pharm, on one pageLotus Pharm (1795) snapshot, key figures
Lotus Pharm (1795): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 243 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→1795: common questions
What is 1795's P/E ratio?
1795 traded at a price-to-earnings ratio of 12.76x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 1795's price-to-book ratio?
1795's price-to-book ratio was 2.05x on 2026-08-03, taken as-is from the official public source.
What is 1795's dividend yield?
1795's cash dividend yield was 1.44% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 1795's revenue growing?
1795 reported 225.5% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 1795's price / earnings high or low right now?
1795's price / earnings is 12.76x, which is below its one-year median of 13.54x and sits at the 31st percentile of the 10.06–20.17x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 1795's price / book high or low right now?
1795's price / book is 2.05x, which is below its one-year median of 2.62x and sits at the 3rd percentile of the 1.89–4.30x range observed over the last 243 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.